home/news/ De Lama in the NANOREMEDI project, a European consortium with Horizon funding, to design nano-scaffolds for regenerative medicine
De Lama in the NANOREMEDI project, a European consortium with Horizon funding, to design nano-scaffolds for regenerative medicine
De Lama is proud to be part of Nanoremedi, an important new research project funded by the European Union, through a ‘Horizon’ grant, in which participate 6 European Universities (University of Milan, University of Pavia, Universitat Politecnica de Catalunya, Hebrel University of Jerusalem, Universite de Montpellier and the Asociacion Centro de Investigacion cooperativa en Nanociencias CIC Nanogune) which together have created a consortium and 11 European companies which joined as Associated Partners.
Among the latter, in addition to De Lama, we mention Bayer, Ab Medica, Jacobacci & Partners, Italfarmaco, Deloitte, Lynxter, Bio Basic Europe. Find the complete list at this link: www.nanoremedi.eu/associated-partners/
The program will last 3 years.
What is Nanoremedi’s goal?
The goal is to study and design ‘nano-scaffolds’, polymeric structures at the service of regenerative medicine. These are biocompatible structures that can take on different shapes and compositions and that will constitute a substrate that can be used in combination with innovative materials to support tissue regeneration. For example, a potential application will be a structure similar to a stent that can be applied inside veins or coronaries. This will have the goal of promoting tissue regeneration, both through its own structure and thanks to the innovative material it contains which will gradually biodegrade.
The “NanoReMedi” project also aims to define a doctoral model in the field of nanomaterials applied to medicine / regenerative medicine with the training of 13 PhDs.
With reference to the University of Pavia, the project is coordinated by Ida Genta, Professor of Pharmaceutical Technology at the Department of Pharmaceutical Sciences and also involves Dr. Enrica Chiesa, Dr. Rossella Dorati and Dr. Bice Conti, teachers of the same department.
This De Lama technology, supported by an international patent, is already starting to replace the ‘old’ Ethylene Oxide (ETo) sterilization technology, a dangerous and toxic gas and being a cold technology, the potential for sterilizing nano-polymeric structures which would be destroyed in case of application of a traditional heat sterilization technology such as saturated steam or dry heat.
